MDGN Insider Trading Activity and SEC Form 4 Filings
MDGN insider trading summary
No open-market insider purchases or sales of Medgenics, Inc. (MDGN) have been reported on SEC Form 4 in the past 12 months.
Latest MDGN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 8, 2016 | Joseph J Grano Jr | Director | Buy | $16K (3,000 @ $5.27) |
| Oct 6, 2015 | Sol J Barer | Director | Buy | $1000K (153,846 @ $6.50) |
| Oct 6, 2015 | Michael F Cola | President and CEO | Buy | $250K (38,460 @ $6.50) |
| Oct 6, 2015 | Garry Arthur Neil | Chief Scientific Officer | Buy | $100K (15,384 @ $6.50) |
| Oct 6, 2015 | Joseph J Grano Jr | Director | Buy | $100K (15,384 @ $6.50) |
| Sep 21, 2015 | Isaac Blech | Director | Sell | $944K (94,825 @ $9.96) |
| Mar 20, 2015 | Sol J Barer | Director | Buy | $422K (50,000 @ $8.45) |
| Mar 20, 2015 | Eugene A Bauer | Director | Sell | $422K (50,000 @ $8.45) |
| Feb 20, 2015 | Sol J Barer | Director | Buy | $378K (50,000 @ $7.55) |
| Feb 19, 2015 | Sol J Barer | Director | Buy | $738K (100,000 @ $7.38) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.